European Association for Predictive Preventive & Personalised Medicine. Personalised medicine in the European Union
Kinkorová, J.
Casopis Lekaru Ceskych 150(7): 402-404
2011
ISSN/ISBN: 0008-7335
PMID: 22026265
Accession: 053053188
PDF emailed within 1 workday: $29.90
Related References
Golubnitschaja, O.; Costigliola, V. 2012: General report & recommendations in predictive, preventive and personalised medicine 2012: white paper of the European Association for Predictive, Preventive and Personalised Medicine Epma Journal 3(1): 14Golubnitschaja, O.; Swanton, C.; Danesi, R.; Costigliola, V. 2011: Promoting predictive, preventive and personalised medicine: European event of global importance Epma Journal 2(2): 131-136
Hickman, J.A.; Tannock, I.F.; Meheus, L.; Hutchinson, L. 2021: The European Union and personalised cancer medicine European Journal of Cancer 150: 95-98
Hasler, P.W.; Flammer, J. 2010: Predictive, preventive and personalised medicine for age-related macular degeneration Epma Journal 1(2): 245-251
Gefenas, E.; Cekanauskaite, A.; Tuzaite, E.; Dranseika, V.; Characiejus, D. 2011: Does the "new philosophy" in predictive, preventive and personalised medicine require new ethics? Epma Journal 2(2): 141-147
Hu, R.; Wang, X.; Zhan, X. 2013: Multi-parameter systematic strategies for predictive, preventive and personalised medicine in cancer Epma Journal 4(1): 2
Coggi, P.T. 2011: A European view on the future of personalised medicine in the EU European Journal of Public Health 21(1): 6-7
Russell, A.; Adua, E.; Ugrina, I.; Laws, S.; Wang, W. 2018: Unravelling Immunoglobulin G Fc N-Glycosylation: A Dynamic Marker Potentiating Predictive, Preventive and Personalised Medicine International Journal of Molecular Sciences 19(2)
Golubnitschaja, O. 2013: The EPMA Journal introduces a new type of research article dedicated to predictive, preventive and personalised medicine Epma Journal 4(1): 11
Hagan, S.; Martin, E.; Enríquez-de-Salamanca, A. 2016: Tear fluid biomarkers in ocular and systemic disease: potential use for predictive, preventive and personalised medicine Epma Journal 7: 15
Rukhadze, T. 2013: An overview of the health care system in Georgia: expert recommendations in the context of predictive, preventive and personalised medicine Epma Journal 4(1): 8
Avishai, E.; Yeghiazaryan, K.; Golubnitschaja, O. 2017: Impaired wound healing: facts and hypotheses for multi-professional considerations in predictive, preventive and personalised medicine Epma Journal 8(1): 23-33
Fisher, R.; Larkin, J.; Swanton, C. 2011: Delivering preventive, predictive and personalised cancer medicine for renal cell carcinoma: the challenge of tumour heterogeneity Epma Journal 3(1): 1
Samec, M.; Liskova, A.; Koklesova, L.; Samuel, S.Mathews.; Zhai, K.; Buhrmann, C.; Varghese, E.; Abotaleb, M.; Qaradakhi, T.; Zulli, A.; Kello, M.; Mojzis, J.; Zubor, P.; Kwon, T.Kyu.; Shakibaei, M.; Büsselberg, D.; Sarria, G.R.; Golubnitschaja, O.; Kubatka, P. 2020: Flavonoids against the Warburg phenotype-concepts of predictive, preventive and personalised medicine to cut the Gordian knot of cancer cell metabolism Epma Journal 11(3): 377-398
Horgan, D.; Romao, M.; Hastings, R. 2017: Pulling the Strands Together: MEGA Steps to Drive European Genomics and Personalised Medicine Biomedicine Hub 2(Suppl 1): 169-179
Golubnitschaja, O.; Flammer, J. 2018: Individualised patient profile: clinical utility of Flammer syndrome phenotype and general lessons for predictive, preventive and personalised medicine Epma Journal 9(1): 15-20
Golubnitschaja, O.; Filep, N.; Yeghiazaryan, K.; Blom, H.Johannes.; Hofmann-Apitius, M.; Kuhn, W. 2018: Multi-omic approach decodes paradoxes of the triple-negative breast cancer: lessons for predictive, preventive and personalised medicine Amino Acids 50(3-4): 383-395
Shapira, N. 2013: Women's higher health risks in the obesogenic environment: a gender nutrition approach to metabolic dimorphism with predictive, preventive, and personalised medicine Epma Journal 4(1): 1
Guilleminault, L.; Ouksel, H.; Belleguic, C.; Le Guen, Y.; Germaud, P.; Desfleurs, E.; Leroyer, C.; Magnan, A. 2017: Personalised medicine in asthma: from curative to preventive medicine European Respiratory Review: An Official Journal of the European Respiratory Society 26(143)
Leopold, C.; Vogler, S.; Habl, C.; Mantel-Teeuwisse, A.K.; Espin, J. 2013: Personalised medicine as a challenge for public pricing and reimbursement authorities – A survey among 27 European countries on the example of trastuzumab Health Policy 113(3): 313-322